{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:06:46Z","timestamp":1768680406796,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,4]]},"DOI":"10.7759\/cureus.89385","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T06:45:56Z","timestamp":1754376356000},"source":"Crossref","is-referenced-by-count":2,"title":["Synchronous Human Papillomavirus (HPV)-Positive Oropharyngeal Carcinoma and Occult Papillary Thyroid Carcinoma: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Tung-Sen","family":"Tai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17349","article-title":"Multiple primary malignancies in head and neck cancer: a university hospital experience over a five-year period","volume":"13","author":"Batista MV","year":"2021","unstructured":"Batista MV, Ulrich J, Costa L, Ribeiro LA. Multiple primary malignancies in head and neck cancer: a university hospital experience over a five-year period. Cureus. 2021, 13:e17349. 10.7759\/cureus.17349","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14164061","article-title":"Human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of clinical trial demographics","volume":"14","author":"Gordis TM","year":"2022","unstructured":"Gordis TM, Cagle JL, Nguyen SA, Newman JG. Human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of clinical trial demographics. Cancers (Basel). 2022, 14:14-6. 10.3390\/cancers14164061","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.10.002","article-title":"Evolving understanding of the epidemiology of thyroid cancer","volume":"48","author":"Seib CD","year":"2019","unstructured":"Seib CD, Sosa JA. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin North Am. 2019, 48:23-35. 10.1016\/j.ecl.2018.10.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.anorl.2019.04.002","article-title":"Head and neck carcinoma of unknown primary","volume":"136","author":"Kennel T","year":"2019","unstructured":"Kennel T, Garrel R, Costes V, Boisselier P, Crampette L, Favier V. Head and neck carcinoma of unknown primary. Eur Ann Otorhinolaryngol Head Neck Dis. 2019, 136:185-92. 10.1016\/j.anorl.2019.04.002","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"ref5","article-title":"HPV-mediated (p16+) oropharyngeal cancer","author":"O'Sullivan B","year":"2017","unstructured":"O'Sullivan B, Lydiatt WM, Haughey BH, et al.. HPV-mediated (p16+) oropharyngeal cancer. AJCC Cancer Staging Manual. 8th Edition. Amin MB, Edge SB, Greene FL, et al. (ed): Springer,  New York, NY; 2017. 4:113-6."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer EA","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al.. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45:228-47. 10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2023.05.005","article-title":"The 2023 Bethesda System for reporting thyroid cytopathology","volume":"12","author":"Ali SZ","year":"2023","unstructured":"Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. The 2023 Bethesda System for reporting thyroid cytopathology. J Am Soc Cytopathol. 2023, 12:319-25. 10.1016\/j.jasc.2023.05.005","journal-title":"J Am Soc Cytopathol"},{"key":"ref8","article-title":"Thyroid-differentiated and anaplastic carcinoma","author":"Tuttle M","year":"2017","unstructured":"Tuttle M, Morris LF, Haugen BR, et al.. Thyroid-differentiated and anaplastic carcinoma. AJCC Cancer Staging Manual. 8th Edition. Amin MB, Edge SB, Greene FL, et al. (ed): Springer,  New York, NY; 2017. 4:873-901."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-031521-041424","article-title":"Oropharyngeal carcinoma with a special focus on HPV-related squamous cell carcinoma","volume":"18","author":"Ferris RL","year":"2023","unstructured":"Ferris RL, Westra W. Oropharyngeal carcinoma with a special focus on HPV-related squamous cell carcinoma. Annu Rev Pathol. 2023, 18:515-35. 10.1146\/annurev-pathmechdis-031521-041424","journal-title":"Annu Rev Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-022-00941-9","article-title":"Induction chemotherapy in low-risk HPV+ oropharyngeal cancer","volume":"23","author":"Dolezal JM","year":"2022","unstructured":"Dolezal JM, Rosenberg AJ. Induction chemotherapy in low-risk HPV+ oropharyngeal cancer. Curr Treat Options Oncol. 2022, 23:54-67. 10.1007\/s11864-022-00941-9","journal-title":"Curr Treat Options Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26696","article-title":"HPV-associated oropharyngeal cancer de-escalation strategies and trials: past failures and future promise","volume":"124","author":"Zakeri K","year":"2021","unstructured":"Zakeri K, Dunn L, Lee N. HPV-associated oropharyngeal cancer de-escalation strategies and trials: past failures and future promise. J Surg Oncol. 2021, 124:962-6. 10.1002\/jso.26696","journal-title":"J Surg Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2011.05.013","article-title":"Pattern of cervical lymph node metastasis in tonsil cancer: predictive factor analysis of contralateral and retropharyngeal lymph node metastasis","volume":"47","author":"Chung EJ","year":"2011","unstructured":"Chung EJ, Oh JI, Choi KY, Lee DJ, Park IS, Kim JH, Rho YS. Pattern of cervical lymph node metastasis in tonsil cancer: predictive factor analysis of contralateral and retropharyngeal lymph node metastasis. Oral Oncol. 2011, 47:758-62. 10.1016\/j.oraloncology.2011.05.013","journal-title":"Oral Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.06.2450","article-title":"Distribution of cervical lymph node metastases from squamous cell carcinoma of the oropharynx in the era of risk stratification using human papillomavirus and smoking status","volume":"96","author":"Amsbaugh MJ","year":"2016","unstructured":"Amsbaugh MJ, Yusuf M, Cash E, et al.. Distribution of cervical lymph node metastases from squamous cell carcinoma of the oropharynx in the era of risk stratification using human papillomavirus and smoking status. Int J Radiat Oncol Biol Phys. 2016, 96:349-53. 10.1016\/j.ijrobp.2016.06.2450","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.wjorl.2020.01.011","article-title":"Unusual locations for differentiated thyroid cancer nodal metastasis","volume":"6","author":"Ranganath R","year":"2020","unstructured":"Ranganath R, Dhillon VK, Shaear M, Rooper L, Russell JO, Tufano RP. Unusual locations for differentiated thyroid cancer nodal metastasis. World J Otorhinolaryngol Head Neck Surg. 2020, 6:176-81. 10.1016\/j.wjorl.2020.01.011","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2021.76836","article-title":"Role and extent of neck dissection for neck lymph node metastases in differentiated thyroid cancers","volume":"55","author":"Aygun N","year":"2021","unstructured":"Aygun N, Kostek M, Isgor A, Uludag M. Role and extent of neck dissection for neck lymph node metastases in differentiated thyroid cancers. Sisli Etfal Hastan Tip Bul. 2021, 55:438-49. 10.14744\/SEMB.2021.76836","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03566-4","article-title":"Meta-analysis of prediction models for predicting lymph node metastasis in thyroid cancer","volume":"22","author":"Liu F","year":"2024","unstructured":"Liu F, Han F, Lu L, Chen Y, Guo Z, Yao J. Meta-analysis of prediction models for predicting lymph node metastasis in thyroid cancer. World J Surg Oncol. 2024, 22:278. 10.1186\/s12957-024-03566-4","journal-title":"World J Surg Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0367-y","article-title":"Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma","volume":"16","author":"Koo BS","year":"2009","unstructured":"Koo BS, Yoon YH, Kim JM, Choi EC, Lim YC. Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma. Ann Surg Oncol. 2009, 16:1344-7. 10.1245\/s10434-009-0367-y","journal-title":"Ann Surg Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100939","article-title":"Radioiodine therapy in advanced differentiated thyroid cancer: resistance and overcoming strategy","volume":"68","author":"Liu Y","year":"2023","unstructured":"Liu Y, Wang J, Hu X, et al.. Radioiodine therapy in advanced differentiated thyroid cancer: resistance and overcoming strategy. Drug Resist Updat. 2023, 68:100939. 10.1016\/j.drup.2023.100939","journal-title":"Drug Resist Updat"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2010.03.014","article-title":"Cytotoxic chemotherapy for differentiated thyroid carcinoma","volume":"22","author":"Sherman SI","year":"2010","unstructured":"Sherman SI. Cytotoxic chemotherapy for differentiated thyroid carcinoma. Clin Oncol (R Coll Radiol). 2010, 22:464-8. 10.1016\/j.clon.2010.03.014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4666","article-title":"Resistance of papillary thyroid cancer stem cells to chemotherapy","volume":"12","author":"Giuffrida R","year":"2016","unstructured":"Giuffrida R, Adamo L, Iannolo G, et al.. Resistance of papillary thyroid cancer stem cells to chemotherapy. Oncol Lett. 2016, 12:687-91. 10.3892\/ol.2016.4666","journal-title":"Oncol Lett"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/387956-synchronous-human-papillomavirus-hpv-positive-oropharyngeal-carcinoma-and-occult-papillary-thyroid-carcinoma-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T06:46:01Z","timestamp":1754376361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/387956-synchronous-human-papillomavirus-hpv-positive-oropharyngeal-carcinoma-and-occult-papillary-thyroid-carcinoma-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.89385","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,4]]}}}